Fundraising Fox

HealthX Ventures2021 Investments

4 investments dated 2021 · listed companies and verified rows first · show all

Agathosagathos.ioin𝕏Oct 2021SEC filingmedium confidence

CareInsights (formerly Agathos) is a mobile-first platform that delivers personalized peer-comparison insights on clinical metrics directly to physicians via text to drive improvements in care quality and reduce costs.

Digital HealthEnterprise SoftwareHealthtechBoulder, US

Andrew Trees(Executive Officer, Director)STEVE WAYE(Executive Officer, Director)

BoardELISE MILLER HOFFMAN(Director)in

Board seatMark Bakken· per SEC Form D · $6.1M raise · filed Oct 2021

Co-investorsBetter Ventures Central LlcNarrow Gauge VenturesNewfund CapitalCultivation CapitalI2BF Global Ventures

AMOpportunitiesamopportunities.orginOct 2021

AMOpportunities operates a clinical training platform that connects medical, MBBS, and nursing students with clinical placements at U.S. and international healthcare sites, offering visa and immigration support.

B2B MarketplacesEdTechHealthtechMarketplacesSaaSTravel & HospitalityChicago, US

Benjamin Bradley(Executive Officer, Director, Promoter)Kyle Swinsky(President, Co-Founder)Daniel Flores(Executive Officer)Kevin Iverson(Executive Officer)John Danaher(Executive Officer)Mamta Patel(Executive Officer)

Board seatMark Bakken· per SEC Form D

Co-investorsDreamit VenturesChicago Early Growth Ventures (CEGV)Laerdal Million Lives FundM25Oui CapitalPACE Healthcare Capital+1 more

KilterApr 2021SEC filingmedium confidence

Madison, US

Seth Braddock(Executive Officer, Director)

BoardChristopher Eckstrom(Director)Harrie Bakst(Director)Brian Lively(Director)

Board seatMark Bakken· per SEC Form D · $733.1K raise · filed Apr 2021

Co-investorsRock River Capital Partners

One SolsticeAug 2021SEC filingmedium confidence

Madison, US

Vincent Ford(Executive Officer, Director, Promoter)Michael Fenchel(Executive Officer, Director, Promoter)

Board seatMark Bakken· per SEC Form D · $9.4M raise · filed Aug 2021

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.